Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU2017221784B2 - Novel compositions and methods for the treatment of immune related diseases - Google Patents
[go: Go Back, main page]

AU2017221784B2 - Novel compositions and methods for the treatment of immune related diseases - Google Patents

Novel compositions and methods for the treatment of immune related diseases Download PDF

Info

Publication number
AU2017221784B2
AU2017221784B2 AU2017221784A AU2017221784A AU2017221784B2 AU 2017221784 B2 AU2017221784 B2 AU 2017221784B2 AU 2017221784 A AU2017221784 A AU 2017221784A AU 2017221784 A AU2017221784 A AU 2017221784A AU 2017221784 B2 AU2017221784 B2 AU 2017221784B2
Authority
AU
Australia
Prior art keywords
treatment
methods
related diseases
immune related
novel compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017221784A
Other versions
AU2017221784A1 (en
Inventor
Hilary Clark
Dan Eaton
Lino Gonzalez Jr
Jane L. Grogan
Jason Hackney
Kristin D. Harden
Xin Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/039868 external-priority patent/WO2009126688A2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Priority to AU2017221784A priority Critical patent/AU2017221784B2/en
Publication of AU2017221784A1 publication Critical patent/AU2017221784A1/en
Priority to AU2019257492A priority patent/AU2019257492A1/en
Application granted granted Critical
Publication of AU2017221784B2 publication Critical patent/AU2017221784B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to compositions and methods of using those compositions for the diagnosis and treatment of immune related diseases. 9418314_1 (GHMattes)P85193.AU.2
AU2017221784A 2008-04-09 2017-08-30 Novel compositions and methods for the treatment of immune related diseases Active AU2017221784B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2017221784A AU2017221784B2 (en) 2008-04-09 2017-08-30 Novel compositions and methods for the treatment of immune related diseases
AU2019257492A AU2019257492A1 (en) 2008-04-09 2019-10-31 Novel compositions and methods for the treatment of immune related diseases

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US12353008P 2008-04-09 2008-04-09
US61/123,530 2008-04-09
US19427108P 2008-09-26 2008-09-26
US61/194,271 2008-09-26
PCT/US2009/039868 WO2009126688A2 (en) 2008-04-09 2009-04-08 Novel compositions and methods for the treatment of immune related diseases
AU2009233708A AU2009233708B2 (en) 2008-04-09 2009-04-08 Novel compositions and methods for the treatment of immune related diseases
AU2015202123A AU2015202123B2 (en) 2008-04-09 2015-04-24 Novel compositions and methods for the treatment of immune related diseases
AU2017221784A AU2017221784B2 (en) 2008-04-09 2017-08-30 Novel compositions and methods for the treatment of immune related diseases

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2015202123A Division AU2015202123B2 (en) 2008-04-09 2015-04-24 Novel compositions and methods for the treatment of immune related diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2019257492A Division AU2019257492A1 (en) 2008-04-09 2019-10-31 Novel compositions and methods for the treatment of immune related diseases

Publications (2)

Publication Number Publication Date
AU2017221784A1 AU2017221784A1 (en) 2017-09-21
AU2017221784B2 true AU2017221784B2 (en) 2019-11-21

Family

ID=53054442

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2015202123A Active AU2015202123B2 (en) 2008-04-09 2015-04-24 Novel compositions and methods for the treatment of immune related diseases
AU2017221784A Active AU2017221784B2 (en) 2008-04-09 2017-08-30 Novel compositions and methods for the treatment of immune related diseases
AU2019257492A Abandoned AU2019257492A1 (en) 2008-04-09 2019-10-31 Novel compositions and methods for the treatment of immune related diseases

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2015202123A Active AU2015202123B2 (en) 2008-04-09 2015-04-24 Novel compositions and methods for the treatment of immune related diseases

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2019257492A Abandoned AU2019257492A1 (en) 2008-04-09 2019-10-31 Novel compositions and methods for the treatment of immune related diseases

Country Status (1)

Country Link
AU (3) AU2015202123B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4733C1 (en) 2014-08-19 2021-07-31 Merck Sharp & Dohme Corp Anti-TIGIT antibodies
CN108290936B (en) * 2015-08-14 2022-07-12 默沙东公司 Anti-TIGIT antibody
CN121253791B (en) * 2025-12-03 2026-03-06 四川新环科技有限公司 An online monitoring device for garden water quality

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006124667A2 (en) * 2005-05-12 2006-11-23 Zymogenetics, Inc. Compositions and methods for modulating immune responses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5401001B2 (en) * 2002-09-11 2014-01-29 ジェネンテック， インコーポレイテッド Novel compositions and methods for the treatment of immune related diseases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006124667A2 (en) * 2005-05-12 2006-11-23 Zymogenetics, Inc. Compositions and methods for modulating immune responses

Also Published As

Publication number Publication date
AU2015202123A1 (en) 2015-05-14
AU2017221784A1 (en) 2017-09-21
AU2015202123B2 (en) 2017-06-15
AU2019257492A1 (en) 2019-11-21

Similar Documents

Publication Publication Date Title
MX364200B (en) Novel compositions and methods for the treatment of immune related diseases.
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
MX2007016322A (en) Compositions and methods for the diagnosis and treatment of tumor.
PH12013502192A1 (en) Antibodies against human angiopoietin 2
EA201190217A1 (en) SUBSTITUTED 2-ACETAMIDO-5-ARIL-1,2,4-TRIAZOLONES AND THEIR APPLICATION
PH12012500620A1 (en) Compounds
WO2005019258A3 (en) Compositions and methods for the treatment of immune related diseases
MX2009011500A (en) Anti-mdl-1 antibodies.
TN2010000140A1 (en) Compositions and methods for use antibodies against sclerostin
EA201001639A1 (en) COMPOSITIONS AND METHODS FOR THEIR PRODUCTION AND APPLICATION
MX2009008430A (en) Anti-robo4 antibodies and uses therefor.
NZ601793A (en) Methods and compositions for diagnosis and treatment of cancer
UA102251C2 (en) Aminidihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
ZA200702322B (en) Compositions and methods for the diagnosis and treatment of tumor
WO2011106322A3 (en) Biomarkers for acute ischemic stroke
EP2576578A4 (en) Polymorphs of 2'-o-fucosyllactose and producing thereof
MX2012002366A (en) Novel pyrrolidine derived beta 3 adrenergic receptor agonists.
WO2007095050A3 (en) N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase
MA34057B1 (en) Formulations and methods for the diagnosis and treatment of tumor
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
AU2010286532A8 (en) Methods of treatment using anti-oxidized LDL antibodies
WO2010135521A3 (en) Compositions and methods for the therapy and diagnosis of influenza
WO2008112840A3 (en) Novel composition and methods for the treatment of immune related diseases
AU2011279845A8 (en) Novel pyrrolidine derived beta 3 adrenergic receptor agonists
MEP1008A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)